Srivastava Arnav, Joice Gregory A, Patel Hiten D, Manka Madeleine G, Sopko Nikolai A, Wright E James
James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD.
James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD.
Urology. 2018 Apr;114:212-217. doi: 10.1016/j.urology.2017.12.029. Epub 2018 Jan 5.
To further understand the implications of adjuvant radiation on artificial urinary sphincter (AUS) durability in postprostatectomy patients.
One hundred fifty-eight postprostatectomy patients, identified by retrospective chart review, underwent AUS placement by 1 surgeon from 2008 to 2016. Time-to-event analysis measured the effect of adjuvant radiation on all-cause failure, and competing-risks regression stratified failure by cause (infection or erosion, urethral atrophy, mechanical failure).
Adjuvant radiation independently predicted all-cause failure over time (hazard ratio = 4.32, P <.01) When stratifying failure by cause, we find that adjuvant radiation patients have increased risk of infection or erosion complications (hazard ratio = 4.48, P = .03). However, there was no statistical increase in urethral atrophy or mechanical failure. Lastly, among patients who have urethral comorbidities (bladder neck contracture, prior urethral sling, or urethral stricture), those with radiation history have particularly poor outcomes (22.4% revision-free survival at 3 years).
In our series of postprostatectomy patients, adjuvant radiation portends worse AUS device survival over time. Furthermore, this decrease in revision-free survival appears to be concentrated in an increase in infection or erosion complications. Patients with prior urethral injury or manipulation who have also undergone adjuvant radiation should be carefully selected when receiving an AUS as this subset of patients experiences low device survival.
进一步了解辅助放疗对前列腺切除术后患者人工尿道括约肌(AUS)耐用性的影响。
通过回顾性病历审查确定了158例前列腺切除术后患者,在2008年至2016年期间由1名外科医生为其植入AUS。生存时间分析测量了辅助放疗对全因失败的影响,并通过竞争风险回归按原因(感染或侵蚀、尿道萎缩、机械故障)对失败进行分层。
随着时间的推移,辅助放疗可独立预测全因失败(风险比=4.32,P<.01)。当按原因对失败进行分层时,我们发现接受辅助放疗的患者发生感染或侵蚀并发症的风险增加(风险比=4.48,P=.03)。然而,尿道萎缩或机械故障在统计学上没有增加。最后,在患有尿道合并症(膀胱颈挛缩、既往尿道吊带术或尿道狭窄)的患者中,有放疗史的患者预后特别差(3年无翻修生存率为22.4%)。
在我们的前列腺切除术后患者系列中,辅助放疗预示着随着时间的推移AUS装置的生存率更差。此外,无翻修生存率的下降似乎集中在感染或侵蚀并发症的增加上。既往有尿道损伤或接受过手术且接受过辅助放疗的患者在接受AUS时应仔细选择,因为这部分患者的装置生存率较低。